These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20298186)
1. Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: how, when and why? Graham TA; McDonald SA Biochem Soc Trans; 2010 Apr; 38(2):374-9. PubMed ID: 20298186 [TBL] [Abstract][Full Text] [Related]
2. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844 [TBL] [Abstract][Full Text] [Related]
3. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling. Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019 [TBL] [Abstract][Full Text] [Related]
5. Genomic alterations in malignant transformation of Barrett's esophagus. Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression. Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707 [TBL] [Abstract][Full Text] [Related]
8. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Helm J; Enkemann SA; Coppola D; Barthel JS; Kelley ST; Yeatman TJ Clin Cancer Res; 2005 Apr; 11(7):2478-85. PubMed ID: 15814623 [TBL] [Abstract][Full Text] [Related]
9. Natural selection in neoplastic progression of Barrett's esophagus. Maley CC; Reid BJ Semin Cancer Biol; 2005 Dec; 15(6):474-83. PubMed ID: 16043360 [TBL] [Abstract][Full Text] [Related]
10. Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma. Wang XW; Gao HJ; Fang DC J Dig Dis; 2008 May; 9(2):68-71. PubMed ID: 18419638 [TBL] [Abstract][Full Text] [Related]
12. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218 [TBL] [Abstract][Full Text] [Related]
13. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J J Pathol; 2006 Jan; 208(1):100-7. PubMed ID: 16278815 [TBL] [Abstract][Full Text] [Related]
14. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content]. Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415 [TBL] [Abstract][Full Text] [Related]